Results 31 to 40 of about 22,310 (212)

Blockade of neuronal α7-nAChR by α-conotoxin ImI explained by computational scanning and energy calculations. [PDF]

open access: yesPLoS Computational Biology, 2011
α-Conotoxins potently inhibit isoforms of nicotinic acetylcholine receptors (nAChRs), which are essential for neuronal and neuromuscular transmission.
Rilei Yu, David J Craik, Quentin Kaas
doaj   +1 more source

Solution structure of α-conotoxin SI [PDF]

open access: yes, 2000
The nuclear magnetic resonance solution structure of α-conotoxin SI has been determined at pH 4.2. The 36 lowest energy structures show that α-conotoxin SI exists in a single major solution conformation and is stabilized by six hydrogen bonds ...
Hargittai, Balazs   +9 more
core   +1 more source

Self-Assembly Nanostructure of Myristoylated ω-Conotoxin MVIIA Increases the Duration of Efficacy and Reduces Side Effects

open access: yesMarine Drugs, 2023
Chronic pain is one of the most prevalent health problems worldwide. An alternative to suppress or alleviate chronic pain is the use of peptide drugs that block N-type Ca2+ channels (Cav2.2), such as ω-conotoxin MVIIA.
Xiufang Ding   +9 more
doaj   +1 more source

A new member of the gamma-conotoxin family, isolated from Conus princeps displays a novel molecular target [PDF]

open access: yes, 2016
"A novel conotoxin, named as PiVIIA, was isolated from the venom of Conus princeps, a marine predatory cone snail collected in the Pacific Southern Coast of Mexico.
JOHANNA BERNALDEZ SARABIA
core   +1 more source

Synthesis and Biological Activity of Novel α-Conotoxins Derived from Endemic Polynesian Cone Snails

open access: yesMarine Drugs, 2023
α-Conotoxins are well-known probes for the characterization of the various subtypes of nicotinic acetylcholine receptors (nAChRs). Identifying new α-conotoxins with different pharmacological profiles can provide further insights into the physiological or
Yazid Mohamed Souf   +8 more
doaj   +1 more source

Conotoxin Patenting Trends in Academia and Industry

open access: yes, 2022
Sea snails of the genus Conus produce toxins that have been the subjects of numerous studies, projects, publications, and patents over the years. Since Conus toxins were discovered in the 1960s, their biological activity has been thought to have high ...
Licea-Navarro, Alexei F.   +5 more
core   +1 more source

Characterisation of a Novel A-Superfamily Conotoxin [PDF]

open access: yesBiomedicines, 2020
Conopeptides belonging to the A-superfamily from the venomous molluscs, Conus, are typically α-conotoxins. The α-conotoxins are of interest as therapeutic leads and pharmacological tools due to their selectivity and potency at nicotinic acetylcholine receptor (nAChR) subtypes.
David T. Wilson   +6 more
openaire   +6 more sources

Inhibition of Escherichia coli chemotaxis by omega-conotoxin, a calcium ion channel blocker [PDF]

open access: yes, 1993
Escherichia coli chemotaxis was inhibited by omega-conotoxin, a calcium ion channel blocker. With Tris-EDTA-permeabilized cells, nanomolar levels of omega-conotoxin inhibited chemotaxis without loss of motility.
Tisa, Louis S.   +2 more
core   +1 more source

Proteomic analysis of the venom of Conus flavidus from Red Sea reveals potential pharmacological applications

open access: yesJournal of Genetic Engineering and Biotechnology
Background: Venomous marine cone snails produce unique neurotoxins called conopeptides or conotoxins, which are valuable for research and drug discovery.
Mousa O. Germoush   +9 more
doaj   +1 more source

Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management?

open access: yesToxins, 2015
The α9α10-nicotinic acetylcholine receptor (nAChR) has been implicated in pain and has been proposed to be a novel target for analgesics. However, the evidence to support the involvement of the α9α10-nAChR in pain is conflicted.
Sarasa A. Mohammadi   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy